Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials.
about
The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan.Associations between systemic inflammation, mycobacterial loads in sputum and radiological improvement after treatment initiation in pulmonary TB patients from Brazil: a prospective cohort study.No impact of concomitant methotrexate use on serious adverse event and serious infection risk in patients with rheumatoid arthritis treated with bDMARDs: a systematic literature review and meta-analysisRisk of tuberculosis in patients treated with TNF-α antagonists: a systematic review and meta-analysis of randomised controlled trials.Immunoglobulin heavy-chain-binding protein (BiP): a stress protein that has the potential to be a novel therapy for rheumatoid arthritis.European Crohn's and Colitis Organisation Topical Review on IBD in the Elderly.Risk of incident Mycobacterium tuberculosis infection in patients with inflammatory bowel disease: a nationwide population-based study in South Korea.Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.Erythema induratum of Bazin which occurred after tumor necrosis factor antagonist therapy.Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management.Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment.Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment.Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management.Recombinant human lactoferrin modulates human PBMC derived macrophage responses to BCG and LPS.New onset or worsening of psoriasis following biologic therapy: A case series.Endoscopic and clinical responses to anti-tubercular therapy can differentiate intestinal tuberculosis from Crohn's disease.
P2860
Q33751643-CD82D653-E591-4E5E-A31F-BBC7D703FADEQ36096192-95C274CE-B45C-4DB7-85A3-EFB7B1765FC2Q36300250-C0E9D794-325F-4F69-96A4-65A18A04DDB9Q36321264-4BF5F236-44DF-4ADF-8CE8-EBA70CA06357Q38268484-191AD309-01D4-414B-B70F-8F3C6E1DCE76Q38995105-C44F758E-B822-491D-B450-40C53592492EQ39116859-01E9CE92-4C97-44FC-A62E-75EF17BBEDC1Q40045451-D122B09E-C224-4AF0-9722-822B264809DBQ47993553-4D0D6782-3C42-4ACD-B3C8-9D15CEB4B29AQ49508046-21FA92FE-EBB4-4C68-9E43-6A59250A89B6Q49821178-C3DAC4D8-D9F0-4CD6-8412-66333FBC0222Q50098797-2D5FB20C-437F-4289-841C-5B1B33864F2AQ50098937-BD1A1666-5843-48BA-82FF-94CB78226492Q51407200-AC21F673-0668-49D8-AD64-E35187B17C68Q53540208-863B02B7-4782-401C-9937-E87FFE0F4A40Q54723831-D85A810A-F579-4825-B277-A045C2A83A96
P2860
Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Higher risk of tuberculosis re ...... randomized controlled trials.
@en
type
label
Higher risk of tuberculosis re ...... randomized controlled trials.
@en
prefLabel
Higher risk of tuberculosis re ...... randomized controlled trials.
@en
P2093
P2860
P50
P1433
P1476
Higher risk of tuberculosis re ...... randomized controlled trials.
@en
P2093
Alberto Migliore
Alessandro Armuzzi
Andrea Picchianti Diamanti
Bruno Laganà
Lorenzo Ridola
Roberto Lorenzetti
Vincenzo Bruzzese
P2860
P304
P356
10.3109/07853890.2014.941919
P407
P577
2014-08-08T00:00:00Z